<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02542423</url>
  </required_header>
  <id_info>
    <org_study_id>CPP 15/479</org_study_id>
    <nct_id>NCT02542423</nct_id>
  </id_info>
  <brief_title>Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure.</brief_title>
  <official_title>Endocan Predictive Value in Postcardiac Surgery Acute Respiratory Failure. The ENDOLUNG Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire de Besancon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Centre Hospitalier Universitaire de Besancon</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      According to literature data, Endocan can detect the onset of respiratory failure. The
      investigators aim to prove its value also for cardiac surgery patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Endocan is an endothelium derived soluble dermatan sulfate proteoglycan. Literature data
      shows that alterate levels of its blood concentration correlate with the onset of pulmonary
      failure in patients with major trauma and septic shock.

      In cardiac surgery respiratory failure and infections are threatening complications leading
      to mortality rates up to 80%. A rapid diagnosis and treatment of this pathology is crucial to
      improve the clinical outcome.

      Unfortunately specific data for the efficacy of Endocan predictive value in cardiac surgery
      patients are not available.

      The investigators aim to determinate if Endocan can be a helpful tool to identify patients
      developing acute respiratory failure after cardiac surgery and anticipate specific treatment
      in order to improve survival.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Not yet recruiting</last_known_status>
  <start_date>September 2015</start_date>
  <completion_date type="Anticipated">March 2017</completion_date>
  <primary_completion_date type="Anticipated">March 2016</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Changes of Endocan blood levels after cardiac surgery and its correlation with postoperative pulmonary failure</measure>
    <time_frame>from day -1 of the intervention to day 3, one blood sample per day</time_frame>
    <description>The investigators will enroll 150 patients undergoing elective cardiac surgery. Every participant will be prelevated of several blood samples following this time frame : day -1 from intervention, day 0 ( six hours after intervention), day 1 , day 2 , day 3. All patients will be observed to detect all infections, especially pulmonary ones, up to hospital discharge. Endocan blood levels of patients developing pulmonary failure and patients without postoperative respiratory insufficiency will be compared.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Respiratory Failure</condition>
  <condition>Postoperative Complications</condition>
  <arm_group>
    <arm_group_label>patients undergoing cardiac surgery</arm_group_label>
    <arm_group_type>Other</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Endocan blood test samples</intervention_name>
    <arm_group_label>patients undergoing cardiac surgery</arm_group_label>
    <other_name>Endocan</other_name>
    <other_name>Endolung</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Able to give written consent

          -  Elective cardiac surgery

          -  More than 18 years old

        Exclusion Criteria:

          -  Less than 18 years old

          -  urgency / emergency cardiac surgery

          -  pregnancy

          -  refusal

          -  unable to give written consent

          -  oncologic patients

          -  concomitant inflammatory or infective pulmonary disease
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sidney Chocron, MD Ph D</last_name>
    <phone>+33381668662</phone>
    <email>sidney.chocron@univ-fcomte.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Andrea Perrotti, MD</last_name>
    <phone>+33381669416</phone>
    <email>a.perrotti@hotmail.it</email>
  </overall_contact_backup>
  <verification_date>September 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 1, 2015</study_first_submitted>
  <study_first_submitted_qc>September 3, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 7, 2015</study_first_posted>
  <last_update_submitted>September 3, 2015</last_update_submitted>
  <last_update_submitted_qc>September 3, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 7, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire de Besancon</investigator_affiliation>
    <investigator_full_name>Andrea PERROTTI</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Insufficiency</mesh_term>
    <mesh_term>Postoperative Complications</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

